US senator Hatch warns about too little exclusivity in biosimilars bill
27 April 2009
Sue Sutter
Venture capital funding for biotechnology firms will dry up and innovator companies will move jobs outside of the US if a biosimilars measure with insufficient data exclusivity protection passes Congress, US senator
Orrin Hatch said.
Speaking at the Food and Drug Law Institute's (FDLI) annual...
Please Login to read the full article.
27 April 2009
Sue Sutter
Speaking at the Food and Drug Law Institute's (FDLI) annual...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: Hope not enough for Avastin in MBC; Hamburg explains withdrawal
- US Capitol Capsule: Lawmakers give 'Super Congress' two cents' worth on big bucks cuts
- House bill unveiling moves US patent system overhaul another step closer
- US Senate overwhelmingly adopts long-awaited patent reform bill
COMMENT
Other Informa Comment
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
